Citi maintains Buy rating on Amylyx Pharmaceuticals stock after KOL event

Related
Uranium American Resources signs agreement for $3.5 million ...
8 minutes ago
0
BlackSky wins multimillion-dollar contract with new internat...
8 minutes ago
0
IMAX boosts credit facility to $375M
10 minutes ago
0
Eli Lilly's Omvoh wins Health Canada approval for Crohn’s di...
11 minutes ago
0
News Corp announces $1B share repurchase program
11 minutes ago
0
CPI read: Tobacco prices are still running hot
12 minutes ago
0
LQWD acquires additional 57.5 Bitcoin
12 minutes ago
0
Sky Quarry announces strategic digital asset initiative
13 minutes ago
0
The overwhelming majority of HR professionals are using AI b...
18 minutes ago
0
Agilent appoints Rodney Gonsalves as interim CFO following M...
18 minutes ago
0
NNN REIT raises dividend by 3.4% to $0.60
19 minutes ago
0
Earnings Snapshot: Citigroup tops Q2 results, hikes dividend...
19 minutes ago
0
Wall Street analysts cheer as Nvidia set to resume sale of H...
20 minutes ago
0
Polyrizon retains Nasdaq listing following hearings panel
21 minutes ago
0
Uber, Baidu collaborate on autonomous vehicle deployment
22 minutes ago
0
CPI read: Airfares fall for the fourth month in a row
22 minutes ago
0
Trade Desk's S&P 500 inclusion an indicator of constructive ...
24 minutes ago
0
NY Empire State Manufacturing Index rises for first time sin...
26 minutes ago
0
CPI rises 0.3% M/M as expected in June; core CPI rises sligh...
26 minutes ago
0
Canada's inflation rate rises to 1.9% in June
27 minutes ago
0
Popular
رشیدپور ترامپ را به مصاحبه دعوت کرد!
1 week ago
5
هوای تهران «بسیار ناسالم» شد + عکس
1 week ago
5
© FBT Company 2025. All rights are reserved